Search

everythinglearnresearchcommunity

for

Search:↓

Tinea incognito in Iran commonly affects adults and mimics other skin conditions.

Topical minoxidil effectively treats male pattern baldness and prevents hair loss.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Apremilast did not work for treating severe alopecia areata.

Darker hair may lead to higher cortisol readings, suggesting a need to adjust for hair color in studies.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

A patient with complete hair loss regrew all her hair using tofacitinib.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.